Intrinsic Value of S&P & Nasdaq Contact Us

Mettler-Toledo International Inc. MTD NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
65/100
4/7 Pass
SharesGrow Intrinsic Value
$884.10
-34.1%
Analyst Price Target
$1,499.17
+11.8%

Mettler-Toledo International Inc. (MTD) generated $955.77M in operating cash flow for fiscal year 2025. After capital expenditures of $107.12M, free cash flow was $848.65M.

Free cash flow margin was 21.1% of revenue. Cash conversion ratio was 1.1x, indicating earnings are backed by cash.

The company returned $800M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (75/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (76/100, Pass) — $848.65M (21.1% FCF margin) supports a durable competitive advantage
  • INCOME (85/100) — Cash conversion ratio was 1.1x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
VALUE
33/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
76/100
Proven by this page
~
GROWTH
45/100
→ Income
INCOME
85/100
→ Income
Mettler-Toledo International Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $955.77M$955.77M$968.35M$965.87M$859.07M
Capital Expenditure $-107.12M$-107.12M$-103.9M$-105.32M$-121.24M
Free Cash Flow $848.65M$848.65M$864.45M$860.55M$737.83M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message